Last synced on 20 December 2024 at 11:05 pm

Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens

Page Type
Product Code
Definition
An over-the-counter molecular test to detect SARS-CoV-2 is an in vitro diagnostic device for the detection of SARS-CoV-2 in clinical specimens to aid in the diagnosis of SARS-CoV-2 infection. The device is intended to be used by lay users and without health care provider (HCP) intervention in home settings or similar environments.
Physical State
In vitro diagnostic assay reagents and hardware. The device may include chemical components for the amplification of nucleic acid targets. The device may include hardware and software to allow for data collection and review.
Technical Method
Uses nucleic acid amplification technology (NAAT) for the detection of SARS-CoV-2 from clinical samples.
Target Area
upper respiratory clinical specimens
Regulation Medical Specialty
Chemistry
Review Panel
Microbiology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
866.3984
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

Product code QWB is linked to regulation 21CFR866.3984, which does not seem to exist yet. It may be pending at the moment.

Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens

Page Type
Product Code
Definition
An over-the-counter molecular test to detect SARS-CoV-2 is an in vitro diagnostic device for the detection of SARS-CoV-2 in clinical specimens to aid in the diagnosis of SARS-CoV-2 infection. The device is intended to be used by lay users and without health care provider (HCP) intervention in home settings or similar environments.
Physical State
In vitro diagnostic assay reagents and hardware. The device may include chemical components for the amplification of nucleic acid targets. The device may include hardware and software to allow for data collection and review.
Technical Method
Uses nucleic acid amplification technology (NAAT) for the detection of SARS-CoV-2 from clinical samples.
Target Area
upper respiratory clinical specimens
Regulation Medical Specialty
Chemistry
Review Panel
Microbiology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
866.3984
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

Product code QWB is linked to regulation 21CFR866.3984, which does not seem to exist yet. It may be pending at the moment.